New immunosuppressive agents and risk for invasive fungal infections

Immunology and Microbiology

• Immunosuppressive Drug 100%
• Tumor Necrosis Factor Alpha 66%
• Alemtuzumab 66%
• Monospecific Antibody 33%
• Solid 33%
• Mortality Rate 33%
• Prevalence 33%
• Inflammatory Disorder 33%
• Basiliximab 33%
• Interleukin 2 Receptor Antibody 33%
• Incidence 33%
• Organ 33%
• Mould 33%
• Hematopoietic Stem Cell Transplantation 33%